Company press releases
| Released | Company | Title | Industry | Topic |
|---|---|---|---|---|
| 31 Jul 2025 07:00 CEST |
BEKAERT | Bekaert: Halfjaarresultaten 2025 | 55102010 Iron and Steel | Sales |
| 31 Jul 2025 07:00 CEST |
BEKAERT | Bekaert: Résultats du premier semestre 2025 | 55102010 Iron and Steel | Sales |
| 31 Jul 2025 07:00 CEST |
AZELIS GROUP NV | Azelis Delivers 11% Free Cash Flow Growth in H1 2025 | 55201000 Chemicals: Diversified | Commercial results |
| 31 Jul 2025 07:00 CEST |
SYENSQO | Syensqo - Second Quarter 2025 Results | 55101000 Diversified Materials | Corporate life |
| 31 Jul 2025 07:00 CEST |
ONTEX GROUP | Ontex confirms H1 results with revenue and margin decrease in a weaker-than-expected market, while investing significantly and reaching key transformation milestones | 45201020 Personal Products | Income |
| 31 Jul 2025 07:00 CEST |
FAGRON | Fagron delivers strong performance with 11% topline growth and 12% increase in REBITDA for H1 2025 | 20102010 Medical Equipment | Other subject |
| 31 Jul 2025 07:00 CEST |
AZELIS GROUP NV | VRIJE KASSTROOM AZELIS IN H1 2025 MET 11% GEGROEID | 55201000 Chemicals: Diversified | Commercial results |
| 31 Jul 2025 07:00 CEST |
ARGENX SE | argenx Reports Half Year 2025 Financial Results and Provides Second Quarter Business Update | 20103010 Biotechnology | Other subject |
| 31 Jul 2025 07:00 CEST |
SYENSQO | Syensqo - Résultats du Second Trimestre 2025 | 55101000 Diversified Materials | Corporate life |
| 31 Jul 2025 07:00 CEST |
FAGRON | Fagron levert sterke resultaten met een omzetgroei van 11% en 12% stijging van REBITDA in H1 2025 | 20102010 Medical Equipment | Other subject |
| 31 Jul 2025 07:00 CEST |
BEKAERT | Bekaert: 2025 Half Year Results | 55102010 Iron and Steel | Sales |
| 31 Jul 2025 07:00 CEST |
SYENSQO | Syensqo - Resultaten Tweede Kwartaal 2025 | 55101000 Diversified Materials | Corporate life |
| 30 Jul 2025 18:00 CEST |
OXURION | Oxurion ontvangt aangepaste transparantiekennisgeving van Atlas Special Opportunities II LLC | 20103010 Biotechnology | Change in Capital |
| 30 Jul 2025 18:00 CEST |
OXURION | Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atlas | 20103010 Biotechnology | Change in Capital |
| 30 Jul 2025 18:00 CEST |
AZELIS GROUP NV | Azelis: Transparency Notification from FMR LLC | 55201000 Chemicals: Diversified | Other subject |
| 30 Jul 2025 18:00 CEST |
OXURION | Informatie met betrekking tot het Totaal Aantal Stemrechten (Noemer) volgend op Atlas Conversie-Notificatie | 20103010 Biotechnology | Change in Capital |
| 30 Jul 2025 18:00 CEST |
OXURION | Oxurion Receives Amended Transparency Notification from Atlas Special Opportunities II LLC | 20103010 Biotechnology | Change in Capital |
| 30 Jul 2025 18:00 CEST |
BIOTALYS NV | Information on the total number of voting rights and shares | 55201015 Fertilizers | - |
| 30 Jul 2025 18:00 CEST |
AZELIS GROUP NV | Azelis: Transparantiekennisgeving FMR LLC | 55201000 Chemicals: Diversified | Other subject |
| 30 Jul 2025 17:45 CEST |
SYENSQO | Syensqo completes the third tranche of its €300 million Share Buyback Program | 55101000 Diversified Materials | Change in Capital |
| 30 Jul 2025 17:45 CEST |
GIMV | Publication of a transparency notification | 30202010 Asset Managers and Custodians | Other subject |
| 30 Jul 2025 17:45 CEST |
GIMV | Openbaarmaking van transparantiekennisgeving | 30202010 Asset Managers and Custodians | Other subject |
| 30 Jul 2025 17:45 CEST |
GIMV | Publication of a transparency notification | 30202010 Asset Managers and Custodians | Other subject |
| 30 Jul 2025 17:45 CEST |
SYENSQO | Syensqo achève la troisième tranche de son programme de rachat d'actions de €300 millions | 55101000 Diversified Materials | Change in Capital |
| 30 Jul 2025 17:45 CEST |
SYENSQO | Syensqo voltooit de derde tranche van zijn €300 miljoen aandeleninkoopprogramma | 55101000 Diversified Materials | Change in Capital |
| 30 Jul 2025 07:30 CEST |
AEDIFICA | Aedifica NV/SA: 2025 half year financial report | 35102010 Health Care REITs | Commercial results |
| 30 Jul 2025 07:00 CEST |
SOLVAY | Solvay : résultats du deuxième trimestre 2025 | 55201000 Chemicals: Diversified | Corporate life |
| 30 Jul 2025 07:00 CEST |
MELEXIS | Melexis Q2 2025 resultaten | 10102010 Semiconductors | Corporate life |
| 30 Jul 2025 07:00 CEST |
MELEXIS | Melexis Q2 2025 résultats | 10102010 Semiconductors | Corporate life |
| 30 Jul 2025 07:00 CEST |
SOLVAY | Solvay second quarter 2025 results | 55201000 Chemicals: Diversified | Corporate life |
| 30 Jul 2025 07:00 CEST |
SOLVAY | Resultaten Solvay van het tweede kwartaal 2025 | 55201000 Chemicals: Diversified | Corporate life |
| 30 Jul 2025 07:00 CEST |
MELEXIS | Melexis Q2 2025 results | 10102010 Semiconductors | Corporate life |
| 29 Jul 2025 22:45 CEST |
NYXOAH SA | Information on the total number of voting rights and shares | 20102010 Medical Equipment | Other subject |
| 29 Jul 2025 22:45 CEST |
NYXOAH SA | Informations sur le nombre total de droits de vote et d'actions | 20102010 Medical Equipment | Other subject |
| 29 Jul 2025 22:30 CEST |
NYXOAH SA | Nyxoah to Release Second Quarter 2025 Financial Results on August 18, 2025 | 20102010 Medical Equipment | Other subject |
| 29 Jul 2025 22:30 CEST |
NYXOAH SA | Nyxoah Publiera ses Résultats Financiers du Second Trimestre 2025 le 18 Août 2025 | 20102010 Medical Equipment | Other subject |
| 29 Jul 2025 08:34 CEST |
TITAN S.A. | Programme de rachats d'actions | 50101030 Cement | Other subject |
| 29 Jul 2025 08:33 CEST |
TITAN S.A. | Share buyback programme | 50101030 Cement | Other subject |
| 29 Jul 2025 08:00 CEST |
ONTEX GROUP | Kennisgeving transparantieverklaring | 45201020 Personal Products | Share history |
| 29 Jul 2025 08:00 CEST |
ONTEX GROUP | Transparency Declaration Notification | 45201020 Personal Products | Share history |
| 28 Jul 2025 22:05 CEST |
NYXOAH SA | Les Données de l'Étude Pivot DREAM de Nyxoah publiées dans le Journal of Clinical Sleep Medicine | 20102010 Medical Equipment | Other subject |
| 28 Jul 2025 22:05 CEST |
NYXOAH SA | Nyxoah’s DREAM Pivotal Study Data Published in the Journal of Clinical Sleep Medicine | 20102010 Medical Equipment | Other subject |
| 28 Jul 2025 22:00 CEST |
CELYAD ONCOLOGY | Celyad Oncology annonce un placement privé d’un million d’euros | 20103010 Biotechnology | Other financial transaction |
| 28 Jul 2025 22:00 CEST |
CELYAD ONCOLOGY | Celyad Oncology Announces €1 Million Private Placement | 20103010 Biotechnology | Other financial transaction |
| 28 Jul 2025 21:40 CEST |
BIOCARTIS | Algemene vergadering | 20101025 Health Services | General meeting / Board Meeting |
| 28 Jul 2025 21:39 CEST |
BIOCARTIS | General meeting | 20101025 Health Services | General meeting / Board Meeting |
| 28 Jul 2025 18:11 CEST |
GBL | GBL - Transacties op GBL-aandelen 28-07-2025 | 30202000 Diversified Financial Services | Other financial transaction |
| 28 Jul 2025 18:10 CEST |
GBL | GBL - Transactions sur actions propres 28-07-2025 | 30202000 Diversified Financial Services | Other financial transaction |
| 28 Jul 2025 18:09 CEST |
GBL | GBL - Transactions on GBL shares 28-07-2025 | 30202000 Diversified Financial Services | Other financial transaction |
| 28 Jul 2025 18:04 CEST |
VASTNED NV | Vastned: Half-year report for the first semester of 2025 | 35102045 Retail REITs | Corporate life |